We assessed the peripheral blood (PB) neutrophil proportion and the paired serum HMGB1 level of newly diagnosed breast cancer patients and observed that TNBC patient PB had a higher proportion of CD62Ldim neutrophils than that from Non-TNBC patients (Figs. 5b and S4E). Here, HMGB1 is linked to breast cancer.